Figure 5.

Kaplan-Meier estimated relationship between cGVHD and relapse time for AML patients who received transplantation in Iran between 1991 and 2011. There was a significant relationship between survival and relapse time (p<0.001). Chronic Graft Versus Host Disease, No: Survival rate for patients who did not develope cGVHD, Yes: Survival rate for patients who developed cGVHD, No-censored: Time of incidence of death in patients who did not develope cGVHD, Yes-censored: Time of incidence of death in patients who developed cGVHD